MYGN FY 2023 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$487M

FY 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$753M+11.0% YoY

Gross Profit

$517M68.6% margin

Operating Income

-$257M-34.2% margin

Net Income

-$263M-35.0% margin

EPS (Diluted)

$-3.18

Cash Flow

Operating Cash Flow

-$111M

Free Cash Flow

-$184M

Stock-Based Comp.

$41M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$363M

Stockholders' Equity

$783M

Cash & Equivalents

$132M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$753M	$678M	+11.0%
Gross Profit	$517M	$476M	+8.5%
Operating Income	-$257M	-$141M	-83.1%
Net Income	-$263M	-$112M	-135.1%